Kas Institute Of Research Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -100.00%
- Profit Growth -111.37%
- Ebitda 89.90%
- Net Worth -72.43%
- Total Assets -23.65%
About Kas Institute Of Research
Kas Institute Of Research Private Limited (KIORPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 March 2018 (Six years and ten months 21 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amol Shah and Akshay Shah serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100PN2018PTC175349
-
Company No.
175349
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Mar 2018
-
Date of AGM
20 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Kas Institute Of Research?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amol Shah
|
Director | 13-Mar-2018 | Current |
|
Akshay Shah
|
Director | 27-May-2021 | Current |
Financial Performance of Kas Institute Of Research.
Kas Institute Of Research Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 111.37% decrease in profit. The company's net worth observed a substantial decline by a decrease of 72.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kas Institute Of Research?
In 2023, Kas Institute Of Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Eris M. J. Biopharm Private LimitedAmol Shah and Akshay Shah are mutual person
-
Camlin Fine Sciences LimitedAmol Shah is a mutual person
-
Fine Aroma Specialities Private LimitedAmol Shah is a mutual person
-
Fine Fragrances Private Limited
Amol Shah is a mutual person
-
Fine Aromatics And Herbal Extracts Private LimitedAmol Shah is a mutual person
-
M. J. Biopharm Private Limited
Amol Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kas Institute Of Research?
Unlock and access historical data on people associated with Kas Institute Of Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kas Institute Of Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kas Institute Of Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
